Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Lockdowns resulted in drastic changes to daily routines, study reveals

Some spent an extra hour a day on chores and childcare during lockdowns, while others got an added daily hour of solo leisure time - and most of us reduced time spent on paid work by around half an hour a day.

3 Nov 2021

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

A comprehensive characterization of the immune responses between SARS-CoV-2 infected individuals with wildtype (WT) and Δ382 SARS-CoV-2.

3 Nov 2021

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Researchers evaluate the safety and immunogenicity of an influenza vaccine and mRNA-based COVID-19 vaccine that were administered concomitantly.

3 Nov 2021

Cross-reactive immunity against coronaviruses

Researchers review the heterologous immunity to coronaviruses and the extent of immune cross-reactivity against SARS-CoV-2.

3 Nov 2021

Research could lead to new methods for tracking COVID-19

The last issue of Wiley's Research Headlines highlighted part one of a study in Environmental Toxicology and Chemistry that involved analysis of sludge from a wastewater treatment plant in Connecticut, and revealed trends in levels of chemicals such as pharmaceuticals and drugs during the first wave of the COVID-19 pandemic.

3 Nov 2021

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Yokogawa announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services.

From Yokogawa Electric Corporation 3 Nov 2021

Impact of SARS-CoV-2 infection on human semen quality

A new review article aimed to extract, review and summarize these articles from the mentioned databases to determine the link between SARS-CoV-2 infection and semen quality.

3 Nov 2021

Unvaccinated? Don’t count on leaving your family death benefits

These days, workers who refuse to get vaccinated against covid-19 may face financial repercussions, from higher health insurance premiums to loss of their jobs.

3 Nov 2021

Humoral immunity following heterologous and homologous COVID-19 vaccination regimens

Researchers sought to analyze immune responses after homologous vaccinations or after heterologous Vector/mRNA vaccinations, with respect to anti-COVID-19 immune responses and the development of autoantibodies.

3 Nov 2021

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

Scientists conducted a cohort study and measured the prevalence and the levels of antibody responses to the nucleocapsid protein of SARS-CoV-2 and four seasonal human coronaviruses.

3 Nov 2021

Anti-inflammatory diets in COVID-19

A recent review of research published in the journal Diseases has shown that anti-inflammatory diets can be useful in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or reducing the severity of coronavirus disease 2019 (COVID-19).

3 Nov 2021

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.

3 Nov 2021

RA patients taking glucocorticoids or B-cell therapies may have worse COVID-19 vaccine response

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.

2 Nov 2021

Virtual exercise program can be safe for people with osteoarthritis, research finds

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health outcomes, and helped them feel more socially connected, an important benefit during the pandemic when many people have chosen to avoid in-person exercise classes.

2 Nov 2021

Study: Ultra-low rituximab dose maintains low disease activity for most RA patients

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab maintained low disease activity for up to four years, and rarely needed to switch to other biologic drugs or glucocorticoids to control their disease.

2 Nov 2021

Pandemic News and Research

Further Reading

Lockdowns resulted in drastic changes to daily routines, study reveals

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Cross-reactive immunity against coronaviruses

Research could lead to new methods for tracking COVID-19

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Impact of SARS-CoV-2 infection on human semen quality

Unvaccinated? Don’t count on leaving your family death benefits

Humoral immunity following heterologous and homologous COVID-19 vaccination regimens

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

Anti-inflammatory diets in COVID-19

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

RA patients taking glucocorticoids or B-cell therapies may have worse COVID-19 vaccine response

Virtual exercise program can be safe for people with osteoarthritis, research finds

Study: Ultra-low rituximab dose maintains low disease activity for most RA patients

Study finds link between prior poor mental health and higher COVID-19 infection rates

Study finds high levels of anxiety, depression among medical doctors during COVID-19 pandemic

A novel mathematical approach to COVID-19 planning

The pros and cons of a COVID-19 vaccine booster

Mitigating SARS-CoV-2 infection risks among essential food workers

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News